Recent publications

• Innovations in topical epidermolysis bullosa treatment: integrating advanced dressings, bioactive therapies and tissue-engineered skin

  3 April 2026

  0
• Perception of Parents Regarding Oral Health-Related Quality of Life of Children With Epidermolysis Bullosa: A Cross-Sectional Study

  1 April 2026

  0
• An evaluation of prademagene zamikeracel for the treatment of recessive dystrophic epidermolysis bullosa

  18 March 2026

  0
• Characterisation of the wound microbiome and antimicrobial resistance profiles in clinical isolates from epidermolysis bullosa patients

  7 March 2026

  0
• Systemic inflammation in recessive dystrophic epidermolysis bullosa: a five-year longitudinal study

  5 March 2026

  0
• Observations of dystrophic epidermolysis bullosa patients with collagen VII NC2 truncation provide new insights into anchoring fibril assembly

  3 March 2026

  0
• Developing CRISPR-Based Therapies for Epidermolysis Bullosa: A Comprehensive Review of Current Strategies

  23 February 2026

  0
• Epithelial-Dermal Inflammasome Crosstalk in Cutaneous Squamous Cell Carcinoma

  15 January 2026

  0
• Zinc as a Biomarker of Nutritional Status and Clinical Burden in Recessive Dystrophic Epidermolysis Bullosa: Implications for Preventive Monitoring

  12 January 2026

  0
• An Acid-Oxidising Solution Containing Hypochlorous Acid Reduces Staphylococcus aureus and Improves Bacterial Diversity in Epidermolysis Bullosa Wounds

  2 January 2026

  0